Replies to post #129881 on Biotech Values

[DewDiligence]

Made me think about your theory that Teva's Lovenox origin is Italy.

It’s more than a theory, Idit—see #msg-59485489.

Thanks for checking on the EU patent situation wrt to MNTA’s ‘886-equiavlent patent.

…if someone like Teva does all steps outside the US, then they can launch their generics in the US.

I highly doubt that such a ploy would circumvent MNTA’s patent, and it probably doesn’t matter anyhow.

[jb_118]

…if someone like Teva does all steps outside the US, then they can launch their generics in the US.

I don't think this is true. My understanding from looking into this a while ago is that it doesn't matter where the infringing action takes place. If you import for sale into the US a product whose manufacture would have been in violation of US patent had those actions been taken in the US, the same patent law/protections apply. Otherwise the patent protection is close to pointless.